「mr」の検索結果
55件：1～5件目を表示
-
pproval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumif...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
pproval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumif...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
h of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of RET-700 in J...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf -
oftware for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of software for...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
ral Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designation to the in...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf